Univ of Wisconsin researcher wants to cure Amyotropic Lateral Sclerosis using fetal cells:
http://www.wired.com...tw=wn_tophead_4
He says it already works in rats, and now wants to move to human trials. But what if it fails in humans? Will it set things back farther than if it wasn't tried at all?
Remember that gene therapy attempt in Pennsylvania, where the kid died due to adverse reaction to the Adenovirus insertion vector? Because of that one incident, it imposed heavy restrictions on future recombinant therapeutic trials with humans.
Is there a similar danger with regenerative stem cell medicine?
Comments?
Fetal Cell Therapy for ALS
Started by
manofsan
, Apr 23 2005 07:41 PM
No replies to this topic
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users